Manufacturers Life Insurance Company, The Opti Nose, Inc. Transaction History

Manufacturers Life Insurance Company, The

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$1.17 - $1.94 $22,292 - $36,962	19,053 New	19,053 $27,000
Q1 2021 May 03, 2021	SELL	$3.47 - $4.75 $86,437 - $118,322	-24,910 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$3.2 - $4.98 $13,692 - $21,309	4,279 Added 20.74%	24,910 $103,000
Q2 2020 Aug 10, 2020	BUY	$3.58 - $7.44 $5,434 - $11,293	1,518 Added 7.94%	20,631 $132,000
Q1 2020 May 15, 2020	BUY	$3.49 - $9.2 $9,143 - $24,103	2,620 Added 15.89%	19,113 $86,000
Q4 2019 Feb 14, 2020	SELL	$6.27 - $11.41 $8,752 - $15,928	-1,396 Reduced 7.8%	16,493 $152,000
Q3 2019 Nov 12, 2019	SELL	$4.75 - $8.38 $4,137 - $7,298	-871 Reduced 4.64%	17,889 $130,000
Q2 2019 Aug 14, 2019	BUY	$6.4 - $10.94 $120,064 - $205,234	18,760 New	18,760 $133,000
Q3 2018 Nov 14, 2018	SELL	$12.43 - $29.76 $168,948 - $404,497	-13,592 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$18.75 - $28.46 $234,412 - $355,806	12,502 Added 1146.97%	13,592 $380,000
Q1 2018 May 15, 2018	BUY	$15.91 - $20.82 $1,527 - $1,998	96 Added 9.66%	1,090 $22,000
Q4 2017 Feb 08, 2018	BUY	$15.2 - $20.76 $15,108 - $20,635	994	994 $19,000

88.3M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $42.5M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.